Japan Current Affairs - 2020

RCEP Member States hope India will Rejoin the Proposed Trade Agreement

A virtual inter-sessional ministerial meeting of the proposed free trade agreement of a group of 15 countries from the Indo Pacific region- Regional Comprehensive Economic Partnership (RCEP) was conducted on 23rd June 2020. Apart from the 10 ASEAN countries, Japan, South Korea, New Zealand, Australia and China are the 15 countries that are negotiating for Read More…

Bill to Rename ‘Tonoshiro’ to ‘Tonoshiro Senkaku’ triggered tensions between Japan and China

A group of Islands without inhabitants located at the South China Sea has been a point of disagreement between Japan and China since 1972. The island is known by the name Senkakus in Japan, while in the People’s Republic of China the Islands are known by the name Diaoyu. The island group is at present Read More…

Cipla’s ‘Cipremi’ gets approval for Treatment of COVID-19 Patients in India

In its June 13th, 2020 guidelines for Clinical Management Protocol for COVID-19, the Union Health Ministry as a part of investigational therapy added ‘Remdesivir’ only for restricted emergency use. A week after, on 21st June 2020, Hetero and Cipla Pharmaceuticals were granted approval by the Drug Controller General of India for the production and marketing Read More…

India becomes 12th Largest Holder of US Government Securities at April 2020 end

Despite low returns, the Treasury Securities (are of four types- Bills, Notes, Bonds, Inflation-Protected Securities) backed by the United States Treasury Department is one of the safest assets for any Central Bank around the world. With USD 157.4 billion at the end of April 2020, India has become the 12th largest holder of United States Read More…

Hetero’s injectable ‘Covifor’ gets DCGI approval for COVID-19 Treatment

For the treatment of COVID-19 positive cases, on 21st June 2020, Hyderabad based pharmaceutical company -Hetero Drugs has received approval from the Drug Controller General of India (a department under- CDSCO: Central Drugs Standard Control Organization) for manufacturing and marketing of antiviral drug Remdesivir. Brandname for Marketing Under the brand name ‘Covifor’, Hetero Pharmaceuticals’ generic Read More…